Related Experiment Video
Updated: Jul 19, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Circular RNA PARG adjusts miR-140-3p to influence progression in sepsis
Hongyi Zheng1, Xianghong Liu2, Jinliang Peng2
1Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical College, Jiangxi, 341000, China. youkebei545260460@163.com.
Abstract:
Sepsis has been characterized as a frequent medical problem with high mortality and severe complication medical problem in the intensive care unit (ICU). Here, qRT-PCR was used to examine circRNA PARG expression levels in patients with sepsis and in human pulmonary microvascular endothelial cells (HPMEC). Lipopolysaccharide (LPS)-simulated HPMEC were hybridized using RNA-Fluorescence in situ hybridization to confirm the location of circRNA PARG and miR-140-3p. The biological role of downregulated circRNA PARGin cellular proliferation, apoptosis, and inflammatory and apoptosis responses was evaluated. performed A dual-luciferase reporter assay was performed to determine the relationship between the circRNA PARG with miR-140-3p. In this study,circRNA PARG aberrant expression was found, and the effects of circRNA PARG on lipopolysaccharide (LPS)-stimulated apoptosis of HPMEC cells were further investigated. Down-regulated circRNA PARG led to significant alleviation of LPS-simulated cell apoptosis via inhibition of inflammatory and apoptosis-related genes, while upregulated circRNA PARG exhibited the opposite effects. Further findings indicated that circRNA PARG positively modulated the relative level of miR-140-3p, which has been confirmed using the luciferase reporter assay. Upregulated circRNA PARG led to a reversal of LPS-simulated cells after transfection of miR-140-3p mimic. In general, a novel insight into understanding the important effects of circRNA PARG in sepsis is provided.
Insights
Circular RNA PARG (circRNA PARG) plays a critical role in sepsis by regulating cell apoptosis and inflammation. Downregulation of circRNA PARG alleviates sepsis-induced cell damage, offering potential therapeutic insights.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Sepsis is a life-threatening condition with high mortality, often complicated in intensive care units (ICUs).
- Understanding the molecular mechanisms underlying sepsis pathogenesis is crucial for developing effective treatments.
- Circular RNAs (circRNAs) are emerging as key regulators in various biological processes, including inflammatory diseases.
Purpose of the Study:
- To investigate the expression and function of circRNA PARG in sepsis.
- To elucidate the role of circRNA PARG in lipopolysaccharide (LPS)-induced human pulmonary microvascular endothelial cell (HPMEC) apoptosis and inflammation.
- To determine the relationship between circRNA PARG and miR-140-3p in the context of sepsis.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure circRNA PARG expression in sepsis patients and HPMECs.
- RNA-Fluorescence in situ hybridization (FISH) to localize circRNA PARG and miR-140-3p.
- LPS stimulation of HPMECs to mimic sepsis conditions.
- Dual-luciferase reporter assay to confirm the interaction between circRNA PARG and miR-140-3p.
Main Results:
- CircRNA PARG exhibited aberrant expression in sepsis.
- Downregulation of circRNA PARG significantly alleviated LPS-induced HPMEC apoptosis by inhibiting inflammatory and apoptosis-related genes.
- CircRNA PARG positively modulated miR-140-3p levels, and its upregulation reversed LPS-induced cell damage after miR-140-3p mimic transfection.
Conclusions:
- CircRNA PARG is implicated in the pathogenesis of sepsis.
- CircRNA PARG influences LPS-induced endothelial cell apoptosis and inflammation, partly through its interaction with miR-140-3p.
- CircRNA PARG represents a potential therapeutic target for sepsis management.
Related Concept Videos
MicroRNAs
Experimental RNAi
Translational Regulation
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
piRNA - Piwi-interacting RNAs

